|
Identification of FGFR2/3 fusions from clinical cfDNA NGS using a de novo fusion caller. |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
| |
|
Employment - GRAIL; Guardant Health |
Stock and Other Ownership Interests - GRAIL; Guardant Health; Illumina |
Patents, Royalties, Other Intellectual Property - GRAIL; Guardant Health; Illumina |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health; Personalis |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
| |
|
No Relationships to Disclose |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Research Funding - Guardant Health |
Patents, Royalties, Other Intellectual Property - Guardant Health |
Travel, Accommodations, Expenses - Guardant Health |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
| |
|
Employment - Guardant Health |
Leadership - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Patents, Royalties, Other Intellectual Property - Guardant Health |
| |
|
Employment - Guardant Health |
Leadership - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Research Funding - Guardant Health |
Patents, Royalties, Other Intellectual Property - Guardant Health |
Travel, Accommodations, Expenses - Guardant Health |